|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 9/12 | |
| A61K 31/557 | |||
| A61K 9/00 | |||
| A61K 31/192 |
| (11) | Number of the document | 2026816 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07783735.9 |
| Date of filing the European patent application | 2007-05-14 | |
| (97) | Date of publication of the European application | 2009-02-25 |
| (45) | Date of publication and mention of the grant of the patent | 2018-10-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/068884 |
| Date | 2007-05-14 |
| (87) | Number | WO 2007/134292 |
| Date | 2007-11-22 |
| (30) | Number | Date | Country code |
| 800016 P | 2006-05-15 | US |
| (72) |
OLSCHEWSKI, Horst, US
ROSCIGNO, Robert, US
RUBIN, Lewis, J., US
SCHMEHL, Thomas, US
SEEGER, Werner, US
STERRITT, Carl, US
VOSWINCKEL, Robert, US
|
| (73) |
United Therapeutics Corporation,
1110 Spring Street, Silver Spring, MD 20910,
US
|
| (54) | TREPROSTINIL ADMINISTRATION USING A METERED DOSE INHALER |
| TREPROSTINIL ADMINISTRATION USING A METERED DOSE INHALER |